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Lentiviral vectors are attractive tools to transduce dividing and nondividing cells. Human tonsillar B lymphocytes have been purified and
induced to proliferate by the addition of anti-CD40 + IL-4 or anti-CD40 + anti-A signals and transduced at high MOI with a VSV
pseudotyped lentivector carrying the eGFP gene under the control of the PGK promoter. Parallel cultures of PHA-stimulated T lymphocytes
containing a comparable amount of cycling cells during the infection reached over 70% eGFP transduction. By contrast, only less than 3% B
lymphocytes became eGFP positive after 7 days from transduction. Molecular analysis of the viral life cycle shows that cytoplasmic
retrotranscribed cDNA and nuclear 2LTR circles are detectable at lower levels and for a shorter period of time in proliferating B cells with
respect to proliferating T lymphocytes. Moreover, FACS-sorted eGFP-positive and negative B cell populations were both positive for the
presence of retrotranscribed cDNA and 2LTR circles nuclear forms. By contrast, nested Alu-LTR PCR allowed us to detect an integrated
provirus in FACS-sorted eGFP-positive cells only. Together with the demonstration that infection in saturation conditions led to an increase in
the percentage of transduced cells (reaching 9%), these findings suggest that in proliferating B lymphocytes, lentiviral transduction is an
inefficient process blocked at the early steps of the viral life cycle possibly involving partially saturable restriction factors.
D 2004 Elsevier Inc. All rights reserved.Keywords: HIV-1; Lentivector; Lymphocyte
Introduction Naldini et al., 1996; Trono, 2000; Zufferey et al., 1997,Retroviral viruses have been used for many years as
vectors to transfer genes into eukaryotic cells (Brenner and
Malech, 2003; Buchschacher and Wong-Staal, 2000; Kay
et al., 2001; Thomas and Kay, 2003; Trono, 2000). The
most utilized murine oncoretroviruses are limited in their
applications to actively dividing cells that lack intact
nuclear membrane and therefore allow reasonably efficient
gene transduction using these vectors (Brenner and Mal-
ech, 2003; Lewis, 1994; Miller and Miller, 1990; Roe et
al., 1993). Recently, a new class of retroviruses, namely
lentiviruses, have attracted general interest in consideration
of their ability to transduce also nondividing cells (Brenner
and Malech, 2003; Emerman, 2000; Kay et al., 2001;0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.04.038
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E-mail address: mintrona@ospedaliriuniti.bergamo.it (M. Introna).1998). To assess the transducibility of quiescent cells,
HIV-1-derived vectors have been used, which were deleted
of all the accessory proteins and pseudotyped with several
different envelopes. All the findings has demonstrated that
to become significantly transduced, human cells require a
minimal stimulation with cytokines or other factors leading
to exit from the G0 status and transition to the G1a and
G1b phases (Cavalieri et al., 2003; Costello et al., 2000;
Dardalhon et al., 2001a, 2001b; Ducrey-Rundquist and
Trono, 2002; Manganini et al., 2002; Sandrin et al.,
2002; Unutmaz et al., 1999; Verhoeyen et al., 2003).
Nonetheless, these data basically reproduce the observa-
tions obtained with the wild-type HIV-1 virus ((Kinoshita
et al., 1998; Steffens et al., 2002), which demonstrated the
requirement of G1 metabolically activated cells to achieve
transduction. More recently, it has been demonstrated that
beyond the cell cycle phases, retrovirus tropism can be
also restricted by cellular factors, such as Fv1, Ref1, and
Lv1 that inhibit infection by blocking the viral life cycle at
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Cowan et al., 2002; Hatziioannou et al., 2003, 2004;
Serhan et al., 2002; Towers et al., 2000, 2003).
Conflicting results have also been obtained using human
normal B lymphocytes, showing efficient transduction in the
presence of a complex cellular coculture system in vitro
(Bovia et al., 2003), weak transduction after CD40L, and
IL-4 stimulation (Janssens et al., 2003) with either resting and
activated cells (Chinnasamy et al., 2000; Unutmaz et al.,
1999).
In this report, we have investigated more extensively the
issue of B cell transducibility by lentivectors using both
resting and proliferating normal human B cells and haveFig. 1. Schematic drawing of the vector used and of the main forms of cDNA inv
produced by transfection of the plasmid shown schematically in line 1 as detailed in
elsewhere (Follenzi et al., 2000). The vector expresses enhanced green fluoresce
kinase gene (PGK) and contains a 118-bp sequence encompassing the central poly
of 400 bp including the enhancer and promoter from U3 and indicated as DU3 (lin
the gag and env genes (respectively, GA and RRE) are also indicated (line 1). Re
single-stranded retroviral RNA (line 2). The final result is a double-stranded DNA
repeat (LTR) elements (DU3-R-U5) on both ends (line 3). At completion of a sin
provirus (line 5), 1LTR and 2LTR circular forms, and linear DNA. In line 4, the 2
entry. The primers (indicated by black arrows) DU3-s and 5NC2-as amplify a 294
amplify a 200-bp fragment of the 2LTR circular form. The nested primers Alu-s an
LTR PCR a121bp fragment of the integrated proviral form. Probe 1 hybridizes the
detects integrated and episomial DNA, the digestion with BamHI detects integratexplored in depth the different intracellular steps of the viral
life cycle.Results
A small fraction of proliferating human B lymphocytes are
transducible by lentiviral vector
We have used a vesicular stomatitis virus (VSV) pseu-
dotyped HIV-1 vector containing a 118-bp sequence encom-
passing the central polypurine tract (cPPT) as schematized
in Fig. 1. This vector carries a self-inactivating LTR regionolved in nuclear import. The pRRLsin18.cPPT.hPGK.eGFP.Wpre vector is
the Materials and methods. All the structural elements have been described
nt protein (eGFP) driven by the promoter of the human phosphoglycerate
purine tract (cPPT). It carries a self-inactivating LTR region with a deletion
e 1). The primer binding site (PBS) region and the truncated portions from
verse transcription (synthesis of viral double-stranded DNA) initiates from
pre-integration complex with identical terminally redundant long terminal
gle cycle of infection, viral DNA is almost fully processed into integrated
LTR circular form is shown. We used this form to measure the viral nuclear
-bp fragment of the final cDNA product; the primers LTR8-as and LTR9-s
d 5NC2-as and LTR9-s and U5PBS-as amplify in a two rounds nested Alu-
RU5 region, probe 2 hybridizes the eGFP region. The digestion with AflII
ed DNA.
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promoter from U3 (Dull et al., 1998; Zufferey et al.,
1998) and expresses enhanced green fluorescent protein
(eGFP) driven by the promoter of the human phosphoglyc-
erate kinase gene (PGK) (Fig. 1) (Follenzi et al., 2000).
In order to investigate the ability of such vector to
transduce normal human B lymphocytes, total B cells were
purified from tonsils, which showed more than 99% purity
according to CD20 staining (as shown in a representative
experiment in Fig. 3, panel A). Following one overnight
exposure to the vector at an MOI of 20 and additional 7 days
of culture, we could detect only a small percentage of eGFP-
positive cells in CD40-triggered total B lymphocytes stained
with an anti-CD20 PE-conjugated monoclonal antibody
(range from 1% to 4%, mean 2% F1) (Fig. 2, panel A)
after subtracting the background levels of mock infected
lymphocytes. To evaluate whether saturation of restrictionFig. 2. CD40-stimulated human normal B cells are not transduced by the eGFP con
B) were cultured for 72 h in the presence of anti-CD40 + IL-4 (upper panels) or ant
an overnight exposure to virus at an MOI of 20. As a control, T lymphocytes st
conditions (lower panels). Numbers indicate percentages of eGFP-positive cells de
PE-conjugated monoclonal antibody against the B lymphocytes marker CD20 and
infected cells.factors could abrogate lentiviral restriction in B cells,
saturating levels of vector particles (MOI = 200, 500 and
1000) were added at B cell cultures enhancing transduction
by fourfold (range from 8% to 10% eGFP-positive cells,
mean 9 F 1; data not shown). B lymphocytes cultured in
medium alone were not susceptible to transduction (data not
shown).
Thymidine uptake in total B lymphocytes populations
showed that the level of proliferation achieved was similar
to the one observed with PHA-stimulated T lymphocytes
studied in parallel (Fig. 3, panel B). Nonetheless, flow
cytometry analysis demonstrated a striking capacity of this
vector to transfer the reporter gene into proliferating T
lymphocytes (range from 70% to 90%, mean 78% F7)
(Fig. 2, panel C). In these culture conditions and at the same
time point at which viral supernatant is added to the culture
(72 h from the addition of stimuli), B and T lymphocytestaining lentivector. Purified total B cells (panel A) and resting B cells (panel
i-CD40 + anti-A (middle panels), respectively. Cells were then transduced by
imulated for 72 h with PHA and IL-2 (panel C) were infected in the same
tected after 7 days from viral exposure. B lymphocytes were stained with a
analyzed by double immunofluorescence. The left side panels refer to mock-
Fig. 3. Purity and anti-CD40 + IL-4-induced proliferation of total human tonsillar B cells and small resting B cells. Panel A: Cells were isolated from excised
human tonsils and purified by rosetting and negative immunoselection. CD20 expression detected by flow cytometric analysis revealed purity above 99% (a
representative experiment is shown). Panel B: The proliferation of cells was measured by 3[H]thymidine uptake. B lymphocytes (white bars)-unstimulated or
anti-CD40 + IL-4-stimulated, and as control, PHA + IL-2-stimulated T lymphocytes (gray bars) were cultured for 72 h. 3[H]thymidine pulse was performed in
the last 16 h. Panel C: Monoparametric DNA cell cycle analysis of T lymphocytes and total human tonsillar B lymphocytes. PHA + IL-2-stimulated T
lymphocytes and anti-CD40 + IL-4-stimulated total B lymphocytes were cultured for 72 h. At this time, they were analyzed for cell cycle phase. The
percentages of cells in the different phases of the cell cycle are shown into each panel. Panel D: Monoparametric DNA cell cycle analysis of small resting B
lymphocytes. Purified small resting B cells were analyzed for cell cycle phase just before purification (day 0) or at the same time point at which viral
supernatant is added to the culture (day 4). The percentages of cells in the different phases of the cell cycle are shown into each panel.
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exceeding 15% of cells in S/G2M, as determined by
monoparametric cell cycle analysis (Fig. 3, panel C), and
in agreement with previous reports (Golay et al., 1994,
1998; Tangye et al., 2003).
Furthermore, to exclude the possibility that the presence
of in vivo stimulated B cells in the total B population
affected negatively transduction efficiency, we repeated
the experiments using purified small resting B cells, con-
taining cells over 95% in the G0/G1 phases (Fig. 3, panel
D). Using a combination of the polyclonal activators anti-A
and anti-CD40 antibodies, we measured a strong prolifera-
tive response by monoparametric cell cycle analysis also
with this population, comparable to that shown in total B
lymphocytes (Fig. 3, panel D). Nonetheless, when these
proliferating B lymphocytes were exposed to the vector at
high MOI (MOI = 20), also in this case, we could detectonly a very small percentage of eGFP-positive cells (range
from 1% to 4%; mean, 3% F1) (Fig. 2, panel B), although
unstimulated cells were completely resistant to gene trans-
duction (data not shown).
These data demonstrate that under our culture conditions,
both resting and strongly proliferating human B lympho-
cytes are resistant to lentiviral transduction, in complete
contrast to human T lymphocytes.
Lentivectors undergo reverse transcription and nuclear
entry in B lymphocytes
In order to investigate the mechanism of action for such
B cell-specific resistance to lentiviral transduction, we first
evaluated whether the virus had infected the B cells, by
exploring the presence of the reverse transcribed cDNA in
the cytoplasm. To do this, DNAwas extracted from infected
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and 5NC2-as primers (Fig. 1, line 3). Amplified DNA was
then hybridized to the probe 1 spanning a portion of the U5
region, as indicated in Fig. 1, line 3. The kinetics of reverse
transcription was monitored at sequential times (18, 24, 48,
60, and 90 h) after overnight exposure to vector super-
natants, which had been DNAse treated to remove possible
plasmid DNA contamination. The same number of cells
were exposed to identical viral loads and then extracted, and
the DNA normalized before PCR. By this analysis, we
could document in B lymphocytes the presence of retro-
transcribed cDNA 18 h following vector exposure, which
persisted for up to 60 h, and was later (at 90 h) down-
regulated (Fig. 4, panel A). These results have been
obtained in at least three separated experiments, thus ruling
out the possibility that the cDNA from the 90 h sample was
simply lost. By contrast, when we performed a similar
analysis in T lymphocytes, we detected higher levels of
PCR products in T than in B lymphocytes (Fig. 4, panel A),
persisting up to 90 h (Fig. 4, panel A) and later (data
not shown). These data suggest that a cDNA product is
present in B lymphocytes, although at lower levels with
respect to T lymphocytes and persisting for a shorter period
of time.
After completion of reverse transcription, pre-integration
complexes traverse the cell and enter the nucleus. LigasesFig. 4. Analysis of viral entry in CD40-stimulated B lymphocytes. Panel A: Dete
harvested at the indicated time intervals (0–90 h) following overnight exposure
second-strand-transfer products containing the DU3 s/5NC2-as sequences (Fig.
hybridized with probe 1 (Fig. 1). Uninfected cell lysates were used as controls (Ut
and then washed and lysed. 294 bp refers to the size of the amplified fragment. Pan
Cells were exposed to ultracentrifuged vectors overnight at an MOI of 20. Lysates o
PCR with primers specific for 2LTR circles (Fig. 1, line 4) and hybridized with prob
T0 refers to cells, which have been exposed to the vector for few seconds and then
same samples were used for PCR of human h-actin (640-bp amplified fragment) fowithin the nucleus can circularize proviral DNA, before
integration into the host chromosome occurs (Fig. 1, line 4)
(Cullen, 2001; Neil et al., 2001; Zennou et al., 2000).
Although these circles are believed to be nonfunctional,
they can serve as a measure of viral nuclear entry. To assess
whether vector DNA enters the nucleus in B lymphocytes,
PCR was performed to detect 2LTR circles (Fig. 1, line 4) in
the same samples of DNA utilized above.
PCR was performed with oligonucleotides LTR8-as and
LTR9-s, as indicated in Fig. 1, line 4, designed to amplify a
200-bp fragment from 2LTR circular DNA that is formed
only in the nucleus. Amplified DNAwas then hybridized to
probe 1. The PCR analysis documented the presence of
circular forms of viral DNA in B lymphocytes that appeared
later (24 h), with respect to T lymphocytes (18 h), did not
persist after the 60 h time point and were detectable at a
lower levels (Fig. 4). On the contrary, viral circles could be
detected up to 90 h in T cells, although at lower levels than
at 18 h (Fig. 4, panel B). The same results were obtained in
three independent experiments.
The integrated proviral form is detectable in B cells using a
nested Alu-LTR PCR method
We then searched for the possible presence of integrated
proviral forms. Cellular DNA from infected T or B cells wasction of viral retrotranscribed cDNA in B and T lymphocytes. Cells were
to ultracentrifuged vector at an MOI of 20. PCR was then performed for
1, line 3). The amplified DNA samples were run in an agarose gel and
); T0 refers to cells, which have been exposed to the vector for few seconds
el B: Detection of nuclear 2LTR circles in transduced B and T lymphocytes.
f B and T cells made at the indicated times after infection were amplified by
e 1 as indicated in Fig. 1. Uninfected cell lysates were used as controls (Ut);
washed and lysed. 200 bp refers to the size of the amplified fragment. The
r loading control. Data are from one representative experiment out of three.
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(spanning a portion of the eGFP gene) (Fig. 1, line 4 and
line 5), to detect total viral DNA (integrated and episomial
forms) as a linear 3.7 kb band. As a control, we have used
the CEM cell line, which upon transduction with the same
vector, gives consistently 80–90% eGFP-positive cells in
the same experimental conditions (data not shown). Trans-
duced T lymphocytes and CEM cells showed a clear signal
of the expected length, as indicated in Fig. 5A, lanes 6 and
8, respectively. By contrast, no such band could be visual-
ized for B lymphocytes (Fig. 5A, lanes 2 and 4), even after
prolonged exposure of the film (up to 3 weeks, data not
shown). As expected, no band could be detected in all
untransduced cell populations (Fig. 5A, lanes 1, 3, 5, and 7).
The absence of detectable integrated provirus in B cells
was confirmed by BamHI digestion that produced a linear
smear for the integrated DNA in transduced T lymphocytes
and CEM (Fig. 5A, lanes 6a and 8a), but no detectable
signal in transduced B cells (lanes 2a and 4a), even after
prolonged exposure of the film. CEM cells showed an
additional band (lane 8a) of 3.7 kb, possibly due to theFig. 5. Analysis of integrated vector DNA in primary human B lymphocytes. Pan
cells, T cells, and CEM cell line. B lymphocytes separated from two tonsils were s
transduced by overnight exposure to the vector at an MOI 20 and lysed after 96 h. L
culture conditions, but not infected. T lymphocytes stimulated with PHA + IL-2 fo
lanes 5 and 7 are negative controls of T lymphocytes and CEM cells, respectively. T
indicated in Fig. 1. As depicted in Fig. 1, AflII digestion releases a 3.7 kb fragment
The BamHI digest distinguishes between non-integrated (3.7 kb band) and int
transduced human B and T lymphocytes by using nested Alu-LTR PCR. Genomic
either untransduced (Ut) or transduced with lentivector (MOI 20) 96 h after infe
5NC2-as primers and a second ‘‘nested’’ round with LTR9-s and U5PBS-as as sho
(PCR-1 + PCR-2) or only by the second round of amplification (PCR-2 alone). T
detected by Southern blot analysis by using an LTR-specific probe (probe 1, Figpresence of abundant episomial forms which are linearized
after BamHI digestion.
Because standard Southern blot analysis does not allow
to detect very low levels of viral integration, we have also
utilized a more sensitive PCR approach. Genomic DNAwas
extracted from transduced B and T lymphocytes and ana-
lyzed using a previously described nested Alu-LTR PCR
detection method (Chinnasamy et al., 2000; Chun et al.,
1997; Follenzi et al., 2000). Primers designed in the human
Alu and vector U5/PBS boundary region sequences allow
amplification of the junctional fragments overlapping the
integration of the vector in the host genomic DNA. The
second round of PCR using nested primers within the vector
LTR results in the generation of a unique amplification
product only from cells containing the Alu-LTR junctional
fragment. Interestingly, under such conditions, B lympho-
cytes show a clearly detectable and specific PCR signal that,
as expected, is at lower level with respect to that detected in
T lymphocytes (Fig. 5, panel B). These data show that a
small amount of viral integration is detectable in B cells by
nested PCR, but not Southern blot.el A: Southern blot analysis of viral DNA (integrated and episomial) in B
timulated with CD40 + IL-4 for 72 h (tonsil A, lane 2; tonsil B, lane 4), then
anes 1 and 3 represent negative controls of B lymphocytes kept in the same
r 72 h (lane 6) and CEM cells (lane 8) were transduced and lysed as above;
he film was hybridized with a probe specific for the eGFP gene (probe 2) as
from all forms of vector DNA and reveals its total content in infected cells.
egrated viral DNA (smear). Panel B: Detection of integrated provirus in
DNA was isolated from mitogen-stimulated human B and T lymphocytes,
ction. DNA was subjected to a first round of amplification with Alu-s and
wn in Fig. 1, line 5. DNA lysates were amplified by nested Alu-LTR PCR
he amplification products were resolved in an agarose gel and bands were
. 1). The amplified 121 bp product is indicated.
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in B lymphocytes
To more directly and positively assess the transduction
and integration by lentivectors in B lymphocytes, we FACS-
sorted the eGFP-positive and eGFP-negative B lymphocytes
5 days after the transduction procedure. All three PCR
experiments were then performed on both populations to
detect reverse transcription, 2LTR circles, and viral integra-
tion, as above.
As evident from the analysis of reverse transcription
(Fig. 6, panel B) and of the 2LTR circles (Fig. 6, panel
C), these two stages of the viral cycle could be measured in
both eGFP-negative (M2, panel A) and eGFP-positive (M1,
panel A) populations, even if positive selected cells (M1)
showed higher levels of signal in both cases (panels B and
C). More importantly, when we performed nested Alu-LTR
PCR of such two populations, we could clearly document
retroviral integration only in the eGFP-positive cells (Fig. 6,
panel D). These data suggest that the eGFP-negative cells
are also infected by the virus, but the viral life cycle is not
completed.
All in all, these data suggest that lentiviral entry, cDNA
transcription, and nuclear entry can occur in human-prolif-Fig. 6. Analysis of viral retrotranscribed cDNA, nuclear 2LTR circles, and integrat
ultracentrifuged vectors overnight at an MOI of 20. After 5 days, the eGFP-positiv
(negative population, marker M2, panel A) were sorted and analyzed. Lysates of
primers specific for second-strand-transfer products (panel B) for 2LTR circles (pan
probe 1 as indicated in Fig. 1. Uninfected cell lysates were used as controls (Ut).
fragment) for loading control. Data are from one representative experiment out oerating normal B lymphocytes, even if at lower efficiency
with respect to proliferating T lymphocytes and that DNA
integration is reached only in a B lymphocytes subset.Discussion
We have investigated the transduction of human normal
B lymphocytes by an HIV-1-derived lentivector carrying the
eGFP gene under the control of the PGK promoter. This
vector is a self-inactivating construct due to a U3/LTR
deletion and carries a central polypurine tract (cPPT) ele-
ment that has been shown to maximize the transduction of
several cell types (Dull et al., 1998; Naldini et al., 1996;
Salmon et al., 2000; Uchida et al., 1998; Zennou et al.,
2000; Zufferey et al., 1997, 1998). Moreover, the whole
system of infection lacks the accessory proteins (Aiken,
1995; Chinnasamy et al., 2000; Cullen, 1998; Frankel,
1998; Heinzinger et al., 1994; Segura-Totten, 2001; von
Schwedler et al., 1993) vif, vpr, vpu, and nef, as previously
reported (Zufferey et al., 1997), and the virions are pseu-
dotyped with the VSV envelope G protein.
Although quiescent tonsillar purified B lymphocytes are
not transduced by this vector, a small but measurableed provirus in eGFP sorted B lymphocytes. B lymphocytes were exposed to
e cells (positive population, marker M1, panel A) and eGFP-negative cells
sorted negative (M2) and positive cells (M1) were amplified by PCR with
el C) and for detection of integrated provirus (panel D) and hybridized with
The same samples were used for PCR of human h-actin (640-bp amplified
f three.
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lowing 72 h stimulation with either anti-CD40 and IL-4 or
anti-CD40 and anti-A mitogenic signals (Golay et al., 1994,
1998; Tangye et al., 2003). This very low efficiency of
transduction is remarkable, particularly when compared to
the much higher values obtained in parallel experiments in
human T lymphocytes following 72 h stimulation with PHA
and IL-2 (over 70% eGFP-positive cells). The low efficien-
cy of transduction into B cells was clearly not due to lower
rates of proliferation, because we have repeatedly observed
by propidium iodide staining and thymidine uptake a
comparable percentage of proliferating cells in B and T
lymphocytes under our culture conditions (Golay et al.,
1994, 1998), also in agreement with others’ previous
observations (Tangye et al., 2003).
The molecular analysis of the viral life cycle performed
during the few days following retroviral infection revealed
that the reverse transcribed cDNA and the nuclear forms are
present at lower levels and for a shorter period of time in
proliferating B versus T lymphocytes. As a consequence,
the small amount of provirus integration in activated B
lymphocytes is detectable only by a nested Alu-LTR PCR
method (Chinnasamy et al., 2000; Chun et al., 1997).
Furthermore, when we sorted the eGFP-positive B lym-
phocytes, we could indeed observe the presence of the
cDNA and of the 2LTR circles in both eGFP-positive
and eGFP-negative cells populations, but the provirus in-
tegration was present only in transduced eGFP-positive B
lymphocytes.
Comparing the results obtained in B versus T lympho-
cytes, the observed differences in the intensity of the
hybridization signal for the cDNA and the 2LTR circles
might suggest that the viral intracellular process is mark-
edly less efficient in B versus T lymphocytes, and it is
completed only in a subset of B lymphocytes (those that
will subsequently become eGFP positive). We cannot
however, based on our data, formally prove that the cDNA
retrotranscription or the nuclear entry is less efficient in B
versus T lymphocytes at a single cell level, but certainly
we can document that the whole process that leads to the
proviral integration is inefficient in human-proliferating B
lymphocytes.
Viral entry and cell transduction are brought about and
counterbalanced by a series of cellular proteins and sig-
nals, some of which take place at the level of the
integration complex (Bieniasz, 2003; Cullen, 2001; Daniel
and Skalka, 1999; Daniel et al., 2003; Hatziioannou et al.,
2003; Li et al., 2001; Suzuki, 2002), but much more work
would be required to positively identify the B cell-specific
factor involved in this putative block. Our observation that
infection at saturating doses of virus can lead to a fourfold
increase in transduction may support the hypothesis that a
cellular factor may be responsible for the low efficiency
of the process, similarly to what has been observed for
Fv1, Rev, and Lv1 in mouse, human cells, and monkey
cells, respectively (Besnier et al., 2003; Bisho et al., 2001;Cowan et al., 2002; Hatziioannou et al., 2003, 2004;
Serhan et al., 2002; Towers et al., 2000, 2003).
It is very interesting to compare the same lentiviral vector
using similar transduction conditions on different target cell
types as we (and others) have done in the last several years.
Indeed, the results obtained so far have demonstrated that
lentivectors containing the cPPT element and devoid of the
accessory protein vif, vpr, vpu, and nef are able to maximally
transduce quiescent cells such as peripheral blood monocytes
(Manganini et al., 2002), to transduce very efficiently
activated T lymphocytes (but only after they have entered
the G1a cell cycle phase) (Cavalieri et al., 2003; Chinnasamy
et al., 2000; Dardalhon et al., 2001a, 2001b; Ducrey-Rund-
quist and Trono, 2002; Manganini et al., 2002; Unutmaz et
al., 1999; Verhoeyen et al., 2003) and, by contrast, to
transduce only a minor fraction of fully proliferating B
lymphocytes (Bovia et al., 2003; Chinnasamy et al., 2000;
Janssens et al., 2003; Unutmaz et al., 1999). That human B
lymphocytes can be transduced by lentivectors with minimal
(Janssens et al., 2003) or no efficiency at all (Chinnasamy et
al., 2000; Unutmaz et al., 1999) had already been reported,
but no molecular analysis had been performed in these
studies to monitor the viral life cycle. Only one report, to
the best of our knowledge, indicates the possibility of
overcoming this block by either EBV infection or by cell
contact with T helper cells (Bovia et al., 2003), suggesting
that specific signaling may increase the efficiency of the viral
cycle. By contrast, mouse B cells appear susceptible to
transduction, both in vitro and in vivo, reaching high level
of exogenous gene expression (Janssens et al., 2003; Rossi
and Morgan, 2003). Whatever the mechanism of restrictions
in normal B lymphocytes, it is defective in neoplastic cells
and cell lines that are all efficiently transduced as previously
reported by us and others (Bambacioni et al., 2001; Biagi et
al., 2001; Bonamino et al., 2004; Kipps and Wierda, 2000;
Koya et al., 2002; Mascarenhas et al., 1998; Stripecke et al.,
2000).
In spite of the justified growing interest in the use of
lentivectors for medical research, the claimed ability of
transduction of resting cells is at the moment under scrutiny;
these viruses have certainly a much higher range of trans-
duction with respect to the oncovectors of mouse origin
(Brenner and Malech, 2003; Kay et al., 2001), but the exact
requirements to maximize their potential are still to be
defined; from this point of view, the huge difference
between monocytes and B lymphocytes is of great signifi-
cance and may allow the future identification of cellular
factors that either facilitate or counteract the viral replica-
tion. On the contrary, there is quite an undiscussed consen-
sus on the transducibility of dividing cells by lentivectors:
based also on the present results on the relatively low
susceptibility to transduction of proliferating B lympho-
cytes, it is intriguing to speculate that even in this case,
cell-type-specific factors or signals may play a pivotal role
in determining efficiency of lentiviral transduction and
integration.
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Vector
Vector was produced by transient transfection into 293T
cells as previously described (Manganini et al., 2002).
Briefly, a total of 3  106 293 T cells were seeded in
10 cm Petri dishes 24 h before transfection in Iscove’s
modified Dulbecco’s medium (IMDM, Gibco, InVitrogen,
Milano, Italy), supplemented with 10% fetal bovine serum
(Hyclone, Logan, UT, USA), 100 IU/ml penicillin–strep-
tomycin, and 2 mM glutamine. A total of 20 Ag of plasmid
DNA was used for the transfection: 3.5 Ag of the envelope-
coding plasmid pMD.G, 6.5 Ag of the packaging plasmid
pCMVDR8.74 (Zufferey et al., 1997), and 10 Ag of
transfer vector plasmid pRRLsin18.cPPT.hPGK.GFP.Wpre
(Follenzi et al., 2000) carrying the enhanced green fluo-
rescent protein (eGFP) gene driven by the phosphoglyce-
rate kinase promoter (PGK).
The supernatant was discarded after 14–16 h and the cells
were incubated in RPMI 1640 (Seromed, Berlin, Germany)
supplemented with 10% heat-inactivated FCS, glutamine,
and antibiotics (thereafter called complete RPMI); the con-
ditioned medium was collected after additional 24 h and
filtered through 0.45-Am pore size filters. The vector stock
was concentrated by one round of ultracentrifugation at
20000 rpm for 140 min, as previously described and stored
at 80 jC. Vector stocks were pretreated with 20 U/ml of
DnaseI (InVitrogen) at 37 jC for 1 h to remove contaminating
plasmid DNA just before infection. Titers of the vector
preparations were determined by transduction of CEM cells
by serial dilutions of supernatant and counting of eGFP-
positive CEM cells by FACS, as previously reported (Introna
et al., 1998; Limon et al., 1997). The titers were found to
range from 107 to 108 CEM-transducing units (TU) per
microliter.
Cells
CEM cell line and T lymphocytes
CEM cells (human T lymphoblastoid cell line) were
maintained in complete RPMI at a concentration of 0.5 
106 cells/ml. T lymphocytes were routinely purified from
the peripheral blood of healthy volunteers by Ficoll–
Hypaque (Lymphoprep Nycomed, Pharma, Oslo, Norway),
and Percoll (Pharmacia, Uppsala, Sweden) gradient centri-
fugation, as previously described (Manganini et al., 2002).
The cells were seeded in 12-well plates at 2  106 cells
per well in 1 ml of complete RPMI in the presence of 1
Ag/ml PHA (Murex Biotech, Dartford, England) and 100
U/ml human recombinant (h) IL-2 (Serono, Rome, Italy)
for 72 h before infection.
B lymphocytes
B lymphocytes were purified from freshly excised human
tonsils essentially as described (Golay et al., 1985). Briefly,tonsils were minced to a single cell suspension and centri-
fuged over a Ficoll–Hypaque gradient. T cells were removed
by rosetting with aminoethylisothiouronium bromide-treated
sheep red blood cells and centrifugation through a Ficoll–
Hypaque gradient. In some experiments, the total B cell
fraction collected was further fractionated by sedimentation
at 2500 rpm for 25 min on a discontinuous Percoll gradient
made of 75%, 55%, 50%, 40%, and 30% Percoll. After
centrifugation, the small dense, resting B cells are found at
55/75% interface. The purity of total B cell populations and
resting B cell populations obtained was 95–97%. The cells
were then immunoselected with the B cell isolation Kit
(Miltenyi Biotec, Bergisch Gladbach, Germany), following
the manufacturers’ instruction reaching 99% of purity as
assessed by direct immunofluorescence analysis, using anti-
CD20mAb FITC (clone L27, BD Biosciences, San Jose, CA,
USA). The purified total B cell population obtained was
cultured at 2  106 cells/ml in 12-well plates in complete
RPMI in the presence or in the absence of 10 Ag/ml anti-
CD40 (clone 626.1, a kind gift of Dr. D. Vercelli, University
of Arizona, Tucson, AZ), and in some experiments, of IL-4
(10 ng/ml) for 72 h before infection. Purified resting B cells
were incubated, at 2 106 cells/ml, with anti-CD40 antibody
and 10 Ag/ml goat anti-human A-chain F(ab)2 fragment (ICN
Biomedicals, Eschwege, Germany) for 72 h before infection.
Proliferation of stimulated T and B lymphocytes was mea-
sured 3 days after the beginning of the culture, by an
overnight pulse with 0.5 ACi of [3H]-thymidine (Amersham
Pharmacia Biotech, Milan, Italy). The assay was performed
in triplicate.
Cell cycle analysis
To evaluate the cell cycle phase distribution, cells were
collected immediately after purification or 72 h after the
addition of the proliferation signals and just before the
infection. The cells were fixed in 70% ethanol. For analysis,
the cells were washed in PBS and resuspended in 2 ml PBS
containing 25 Ag/ml propidium iodide (PI) and 25 Al of
RNAase (1 mg/ml in water) and stained for at least 4 h at
room temperature in the dark. The fluorescence pulse was
detected at 620 F 35 nm on at least 10,000 events using a
FACSCalibur instrument (Becton Dickinson, San Jose, CA,
USA). The percentage of cells in the different cell cycle
phases was calculated using the CellFit software (Becton
Dickinson) (Erba et al., 2001; Golay et al., 1985).
Transduction of human B and T lymphocytes
After 72 h of culture in the presence or in the absence of
different stimuli (as above), viral supernatants and poly-
brene (8 Ag/ml) (Sigma, Saint Louis, MI, USA) were added
to the cultures at an MOI of 20. For saturation experiments,
viral supernatants, in the presence of polybrene, were added
at an MOI of 200, 500, and 1000. After an overnight
incubation, the supernatants were replaced with fresh me-
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were analyzed at different times. Transduced B lymphocytes
were stained with anti-human CD20-phycoerythrin (PE)
(Becton Dickinson). To measure eGFP expression, cells
were analyzed after 7 days of culture, until cells displayed
uniform cytoplasmic eGFP, on a FACScan using the Cell-
quest software (Becton Dickinson).
FACS sorting
After 5 days of culture from the exposure to the virus,
eGFP-positive B cells were sorted using a fluorescence-
activated cell sorter (FACS Vantage) and analyzed on a
FACScalibur (Becton Dickinson Systems).
PCR analysis to detect cDNA and 2LTR circles
cDNA and 2LTR circles were amplified as previously
described (Follenzi et al., 2000; Naldini et al., 1996).
Briefly, at different times following viral exposure (from
18 to 90 h), cells were collected, washed, and lysed in
TNE (0.1 M Tris–HCl, pH 8.5, 5 mM EDTA, 0.2% SDS,
0.2 M NaCl) containing Proteinase K (0.7 mg/ml) (Roche,
Indianapolis, USA) at 56 jC for 16 h followed by the
addition of RNAse (0.02 mg/ml) (Roche) for 60 min at 37
jC. Samples were then phenol-chloroform extracted and
ethanol precipitated. The DNA extracted was quantified by
densitometry and resuspended in TE buffer (Tris–HCl, 10
mM; EDTA 1 mM) buffer for PCR analysis in the presence
of 25 pmol of each of the primers, 1 mM dNTPs, and 1.5
U of Taq polymerase (Roche). Primers designed to amplify
double-stranded cDNA generated after the second template
switch were DU3 s: 5V-TCACTCCCAACGAAGAGAA-
GATC-3V and 5NC2 as: 5V-CCGAGTCCTGCGTCGAGA-
GAGC-3V. Amplification conditions were as follows: 94
jC for 3 min, then 30 cycles of 94 jC for 1 min, 58 jC for
1 min, and 72 jC for 1 min, followed by a final extension
at 72 jC for 7 min.
The same DNA preparations were also utilized for the
2LTR circles form. In this case, the primers used were LTR8-
as: 5V-TCCCAGGCTCAGATCTGGTCTAAC-3V and LTR9-
s: 5V-GCCTCAATAAAGCTTGCCTTG-3V, with the follow-
ing amplification conditions: 94 jC for 3 min, then 30 cycles
of 94 jC for 1 min, 60 jC for 1 min, and 72 jC for 1 min,
followed by a final extension at 72 jC for 7 min.
Finally, the DNA amplified was separated on a 1%
agarose gel, transferred to a nylon membrane by capillary
transfer, probed with a 32P-labeled probe spanning the U5
region (thereafter called probe 1) washed in 1  SSC/0.1%
SDS at 60 jC, and exposed it to X-ray film (Kodak). Probe
1 was obtained by NarI/SphI digestion of the plasmid
pRRL.sin18.cPPT.hPGK.GFP.Wpre and purification of the
329 bp band containing the RU5 fragment.
A PCR analysis was also performed on the same DNA
samples to detect human h-actin as a loading control. The
primers used were forward sequence: 5V-GATCATGTTTGAGACCTTCA-3V and reverse sequence: 5V-ACCTTGATCTT
CATGGTGC, with the following amplification conditions:
95 jC for 2min, then 18 cycles of 95 jC for 30 s, 54 jC for 30
s, and 72 jC for 70 s, followed by a final extension at 72 jC
for 5 min.
Southern-blot analysis
The same DNA preparations as above were processed for
Southern analysis as follows: 10 Ag DNA was digested
overnight with AflII and BamHI at 37 jC, separated on a 1%
agarose gel, transferred to a nylon membrane by capillary
transfer, probed with a 32P-labeled eGFP probe (thereafter
called probe 2), washed in 1  SSC/0.1% SDS at 60 jC,
and exposed it to X-ray film.
Nested Alu-LTR PCR for detection of the integrated form of
the lentiviral construct
To demonstrate integration of the lentiviral vector in the
transduced B and T lymphocytes, genomic DNA was puri-
fied from both stimulated primary B and T lymphocytes 96
h after transduction and subjected to nested Alu-LTR PCR as
described previously (Chinnasamy et al., 2000; Chun et al.,
1997). Briefly, the first PCR was carried out using a sense
oligomer, specific for the conserved sequences of human Alu
(Alu-s: 5V-TCCCAGCTACTGGGGAGGCTGAGG-3V)
(Sonza et al., 1996) and an antisense oligomer specific for
the PBS region of the vector (5NC2-as: 5V-GAGTCCTGCG
TCGAGAGAG-3V) (Naldini et al., 1996). In all amplifica-
tions, 100 Al of reaction mixture containing 500 ng of
genomic DNA, 0.4 mM of each dNTP (Roche Diagnostics,
Mannheim, Germany), 0.8 AM of each sense and antisense
primer, 5% DMSO, and 5 U Taq polymerase (AmpliTaq
Gold, Roche, Mannheim, Germany) were used. After the
first DNA denaturation and activation of the enzyme at 95
jC for 10 min, 30 amplification cycles were performed
consisting of denaturation for 1 min at 94 jC, annealing
for 1 min at 57 jC, and extension for 1 min at 72 jC. One
aliquot (10 Al) of the first PCR products was subjected to a
second PCR amplification using the nested primers, LTR9-
sense (5V-GCCTCAATAAAGCTTGCCTTG-3V) and
U5PBS-antisense (spanning the U5LTR/PBS boundary re-
gion) (5V-GGCGCCACTGCTAGAGATTTT-3V), amplifying
a fragment of 121 bp (Follenzi et al., 2000). The nested PCR
conditions were similar to the first amplification differing in
dNTPs and primers concentrations (0.2 and 0.5 AM, respec-
tively), and in the annealing temperature that was 55 jC.
Seventeen amplification cycles were performed. In control
reactions, genomic DNA that had not been subjected to the
first round of PCR was also amplified using the second PCR
primers to exclude the presence of plasmid or residual
nonintegrated vector DNA. PCR products were analyzed
by gel electrophoresis, followed by Southern blot and
hybridization using the 32P-labeled probe 1 as described
above.
M. Serafini et al. / Virology 325 (2004) 413–424 423A PCR analysis was also performed on the same DNA
samples to detect human h-actin as a loading control, as
described above.Acknowledgments
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